Adam J. Rabalski

Adam J. Rabalski has a diverse work experience spanning various organizations and roles. Their most recent position is as an Associate Director of Chemical Biology at Odyssey Therapeutics, starting in 2022. Prior to that, they worked at Scorpion Therapeutics as a Senior Scientist II in Chemical Biology, where they developed high-throughput automation workflows for chemical proteomic sample preparation. Adam also has experience at AbbVie, where they served as a Senior Scientist I in Proteomics, utilizing mass spectrometry-based methods to understand drug-target engagement and off-target characterization of small molecules. Adam J. also worked as a Postdoctoral Research Fellow in Chemical Biology at AbbVie, focusing on developing and optimizing protocols for understanding drug-target engagement. Adam began their career at Western University as a Graduate Student, conducting experiments to study the effects of small-molecule protein kinase inhibitors. Adam J. also has experience in community coordination, serving as a Local Community Coordinator for Succeed Clean anti-doping education presentations at the Canadian Centre for Ethics in Sport. Additionally, Adam has conducted research as an Undergraduate Research Assistant at the University of Guelph, focusing on various topics such as protein interactions, mouse models, and fowl-adenoviruses. Adam J. also worked as a Head Lifeguard and Swimming Instructor at the YMCA-YWCA of Guelph. Overall, Adam's experience includes expertise in chemical biology, proteomics, drug discovery, and laboratory research.

Adam J. Rabalski earned a Bachelor's Degree in Biological and Biomedical Sciences from the University of Guelph in the years 2007-2011. Adam J. then pursued a Doctor of Philosophy (Ph.D.) degree in Biochemistry from Western University from 2011-2017.